LINDSAY PALMERI: Open Payments
NPI 1629439690 · SMITHFIELD, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$641 in 23 payments from 11 companies in 2025. Trend: 2023 $565 · 2024 $610 · 2025 $641
Food & beverage: $641
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 5 | $168 |
| Tris Pharma Inc | 1 | $125 |
| Novo Nordisk Inc | 4 | $79 |
| Lilly USA, LLC | 3 | $47 |
| ABBVIE INC. | 2 | $45 |
| AstraZeneca Pharmaceuticals LP | 2 | $43 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $42 |
| ViiV Healthcare Company | 1 | $27 |
| Exact Sciences Corporation | 1 | $23 |
| PFIZER INC. | 1 | $22 |
Products named: Repatha, Dyanavel XR, Wegovy, MOUNJARO, FARXIGA, CAPLYTA, VRAYLAR, APRETUDE.
Industry payments across NC — which companies pay providers there.
